سعر بروبوفول 1% فريسينيس مستحلب للحقن وريد 2026

Propofol 1% intravenous emulsion (Fresenius Kabi), a short-acting IV general anaesthetic/hypnotic.

• Induction of general anaesthesia (patients 3 years and older)DailyMed (U.S. National Library of Medicine)
• Maintenance of general anaesthesia (patients 2 months and older)DailyMed (U.S. National Library of Medicine)
• Monitored anaesthesia care sedation and sedation with regional anaesthesia in adultsDailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to propofol or any component; history of anaphylaxis to eggs, egg products, soybeans or soy products.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Serious, sometimes fatal hypersensitivity reactions; risk of microbial contamination (strict asepsis, single patient use).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Hypotension, apnoea, airway obstruction and oxygen desaturation, more likely after rapid bolus, especially in elderly, debilitated or ASA-PS III-IV patients; to be administered only by persons trained in anaesthesia/critical care.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Propofol infusion syndrome with ICU infusions (metabolic acidosis, hyperkalaemia, lipaemia, rhabdomyolysis, hepatomegaly, renal and cardiac failure), which can be fatal.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Decades of data have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes; propofol crosses the placenta and neonatal depression has been reported after exposure during delivery.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)